Your First Week on Compounded Semaglutide: What to Expect Day by Day

What to expect in your first week on compounded semaglutide

The first week on compounded semaglutide is primarily about your body adjusting to a new appetite-regulating signal. Most patients start at the 0.25mg weekly starter dose, which is the same starting dose used in the STEP 1 clinical trial for FDA-approved semaglutide (Wegovy). The starter dose is intentionally subtherapeutic — it is designed to acclimate the body to the medication and minimize gastrointestinal side effects, not to produce significant weight loss. Significant weight loss occurs at higher maintenance doses (1.7mg or 2.4mg) after several weeks of titration. Compounded semaglutide is not FDA-approved.

Day 1: Your first injection

Day 1 begins when you take your first weekly subcutaneous injection. Most patients inject in the abdomen (avoiding a 2-inch radius around the navel), thigh, or upper arm. The injection is administered with a small-gauge needle and typically causes minimal discomfort. After the injection, you can resume normal activities immediately. Most patients report no immediate noticeable effects on Day 1 — semaglutide has a long half-life (approximately 165 hours / 7 days) so blood levels rise gradually over the first 3-5 days rather than immediately.

Things to do on Day 1: record the injection date and time in a treatment log, photograph your starting weight and body measurements (these become reference points for tracking progress), and confirm your next injection date one week from today.

Day 2-3: Early adjustment

Days 2 and 3 are when most patients first notice the medication's effects. Common experiences include:

• Mild appetite reduction — meals feel smaller, snacks feel less necessary
• Slight nausea, particularly after meals or in the morning
• Mild fatigue or low energy
• "Food noise" — the persistent mental chatter about food — may begin to quiet, though most patients report this fully resolves later in the first week
• Mild constipation as gastric emptying slows
• Reduced cravings for sweets, alcohol, or rich foods (this varies significantly between individuals)

Day 4-5: Peak side effect window

Days 4-5 are typically the peak of the first-week side effect curve as the medication reaches steady state in your bloodstream. Most patients experience their strongest side effects in this window. Common experiences include slightly more pronounced nausea (typically mild-to-moderate), continued mild fatigue, occasional mild headaches, constipation that may require dietary fiber or magnesium adjustment, and sulfur burps (a distinct rotten-egg smelling burp that some patients report on tirzepatide and occasionally semaglutide).

Most side effects in this window are temporary and resolve as the body adjusts. If side effects are severe — vomiting more than once, inability to keep fluids down for more than a few hours, severe abdominal pain, or signs of dehydration — contact your provider immediately. Severe side effects in the first week are unusual at the 0.25mg starter dose and warrant clinical evaluation.

Day 6-7: Settling in

By days 6-7, most patients report that initial side effects have plateaued or begun to improve. Food noise reduction is typically well-established by this point — many patients describe it as "I just don't think about food the same way." Appetite suppression is noticeable but not extreme at the 0.25mg dose. Most patients are eating approximately 70-85% of their usual meal sizes and feeling full sooner.

Day 7 is also when you take your second weekly injection. Your provider will typically recommend staying at 0.25mg for at least 4 weeks before titrating up to 0.5mg, based on the STEP 1 trial titration protocol. Some patients tolerate the starter dose well enough to extend to 6-8 weeks before titrating; others escalate sooner. Titration decisions should always be made with your prescribing provider.

Common first-week side effects and management

The most common first-week side effects on compounded semaglutide at 0.25mg, and evidence-based management strategies:

What you should NOT expect in the first week

Setting realistic expectations is essential to avoid frustration and premature discontinuation.

• Significant weight loss — the 0.25mg starter dose is subtherapeutic. Most weight loss occurs at the 1.7mg and 2.4mg maintenance doses, after 8-16 weeks of titration.
• Dramatic appetite changes — appetite suppression at the starter dose is moderate. Strong suppression develops at higher doses.
• Complete elimination of food noise — most patients report meaningful but not total reduction in the first week. Full quieting often develops over weeks 2-4.
• Improvement in fitness or energy — many patients experience temporary fatigue during titration. Energy generally normalizes as the body adjusts and as weight loss begins.
• Same effects as patients at maintenance doses — your experience at 0.25mg will not match what other patients describe at 2.4mg.

When to contact your provider during the first week

Contact your prescribing provider immediately during the first week if you experience any of the following:

• Severe vomiting (more than once in a 24-hour period, or inability to keep fluids down)
• Severe abdominal pain, particularly upper-right abdominal pain (possible gallbladder involvement) or sharp epigastric pain (possible pancreatitis warning sign)
• Signs of dehydration: dark urine, dizziness, rapid heart rate, dry mouth
• Allergic reaction signs: rash, hives, swelling of face/lips/tongue, difficulty breathing
• Severe fatigue that prevents normal daily activity
• Heart palpitations or rapid pulse at rest
• Vision changes
• Severe headache that does not respond to OTC analgesics

Frequently asked questions about the first week

Common questions from patients starting compounded semaglutide.

How much weight will I lose in the first week?

Most patients lose 0-3 pounds in the first week on compounded semaglutide at the 0.25mg starter dose. This early weight change reflects reduced caloric intake (due to appetite suppression) plus some water-weight shift, not significant fat loss. The 14.9% mean weight loss figure from the STEP 1 trial reflects 68 weeks at the 2.4mg maintenance dose with combined lifestyle intervention. Compounded versions are not FDA-approved and have not been studied in equivalent trials. Individual results vary substantially.

Can I drink alcohol during the first week?

It is generally recommended to avoid alcohol or limit intake significantly during the first week, particularly during the peak side effect window (days 4-5). Alcohol can worsen nausea, dehydration, and gastrointestinal side effects from semaglutide. After the first week, many patients reintroduce moderate alcohol consumption — though many report reduced desire for alcohol as the medication takes effect. Discuss your individual situation with your prescribing provider.

Should I exercise during the first week?

Light activity (walking, gentle yoga, low-intensity work) is generally encouraged from day 1 and may help with first-week constipation. High-intensity exercise is best deferred until after the peak side effect window (typically days 4-5). Many patients report reduced exercise tolerance during the first week due to fatigue; this normalizes within 2-3 weeks. Maintain adequate protein intake regardless of appetite level to preserve muscle mass during caloric reduction.

What if I miss my second injection?

If you miss your scheduled second injection (typically day 7), take it as soon as you remember — semaglutide has a long half-life so a delay of 1-2 days is typically not clinically significant. If you miss the dose by more than 5 days, consult your prescribing provider before resuming. Do not double the dose to "catch up" — semaglutide is dosed weekly, not by accumulated dose. Set a phone reminder for the same day each week to avoid future missed doses.

When will I notice food noise reduction?

Most patients report meaningful food noise reduction within 3-7 days of the first injection at the 0.25mg dose. Some patients notice it within 24-48 hours; others take 2-3 weeks. "Food noise" — the persistent mental chatter about food, planning meals, or thinking about snacks — is one of the most consistently-reported subjective effects of GLP-1 medications. Reddit patient surveys cited in 2026 research found the most common description is "I just stopped thinking about food," typically within the first 7-14 days of treatment.